Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...
Medpage Today on MSN15d
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin WinThe FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious, class I type due to the risk for ...
Abbott has announced the U.S. availability of Lingo, the company’s first glucose monitoring system available without ...
Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.
Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...
Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback